Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 180(1): 113-21, 1999 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-10089298

RESUMO

The migration of di-2-ethylhexyl phthalate (DEHP) from dialyzers was studied in 21 patients with chronic renal failure undergoing maintenance hemodialysis. The circulating concentrations of DEHP were measured by high performance liquid chromatography in blood of patients obtained from the inlet and the outlet of the dialyzer during a 4-h dialysis session. During treatment of renal failure using plasticized tubing, the plasma level of DEHP increased. On average, an estimated 75.2 mg of DEHP was extracted from the dialyzer during a single dialysis session, with a range of 44.3-197. 1 mg. On the other hand, the total amount of DEHP retained by the patient during the dialysis session was evaluated by the difference between the AUCout and the AUCin and ranged from 3.6 to 59.6 mg. The rate of extraction of DEHP from the dialyzer was correlated (r=0.705, P<0.05) with serum lipid content (cholesterol and triglyceride).So, we confirmed that patients on hemodialysis are always regularly exposed to considerable amounts of DEHP. However, several metabolic effects have been reported in various animal species following treatment with DEHP, such as changes in lipid metabolism and in hepatic microsomal drug-metabolizing enzyme activities. DEHP is now a well-known hepatic peroxisomal proliferator in rodents and an inducer of many peroxisomal and non-peroxisomal enzymes. So, lipid metabolism modifications and hepatic changes observed in hemodialysis patients could be explained from chronic exposition to DEHP. In the coming years, it seems necessary to reconsider the use of DEHP as a plasticizer in medical devices. Highly unacceptable amounts of DEHP leached during the dialysis session could be easily avoided by careful selection of hemodialysis tubing.


Assuntos
Dietilexilftalato/sangue , Diálise Renal/efeitos adversos , Insuficiência Renal/sangue , Adulto , Idoso , Dietilexilftalato/toxicidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência Renal/metabolismo , Fatores de Tempo
2.
J Pharm Biomed Anal ; 21(5): 923-30, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10703960

RESUMO

The stability of quinine was determined in various diluents and in polyvinyl chloride (PVC) containers. The release of diethyhexyl phthalate (DEHP) from PVC bags into intravenous infusions of quinine was also measured. We used an injection of two doses of quinine; quiniforme at 500 mg and quinimax at 400 mg in either 250- or 500-ml PVC infusion bags containing 5% dextrose, to give initial nominal concentrations of 2 or 1 mg ml(-1) quiniforme and 1.6 or 0.8 mg ml(-1) quinimax, the mean concentrations commonly used in clinical practice. Samples were assayed by stability-indicating high-performance liquid chromatography (HPLC) and the clarity was determined visually. Experiments were conducted to determine whether the stability and compatibility of quinine would be compromised, and whether DEHP would be leached from PVC bags and PVC administration sets during storage and simulated infusion. There was no substantial loss of quiniforme and quinimax over 1- or 2-h simulated infusion irrespective of the diluent, and storage during 8 h at 22 degrees C, 48 or 72 h at 4 degrees C and 96 h at 45 degrees C. Leaching of DEHP was also detected during simulated infusion delivery using PVC bags and PVC administration sets. The quantity was less than 2 microg ml(-1). During storage at 4 degrees C and room temperature the leaching of DEHP was low, but when the temperature was 45 degrees C the quantity was high, 21 microg ml(-1). To minimise patient exposure to DEHP, quinine solutions with all drugs should be infused immediately or stored for a maximum of 48 h at 4 degrees C.


Assuntos
Antimaláricos/análise , Embalagem de Medicamentos , Quinina/análise , Antimaláricos/química , Cromatografia Líquida de Alta Pressão , Dietilexilftalato/química , Incompatibilidade de Medicamentos , Estabilidade de Medicamentos , Armazenamento de Medicamentos , Infusões Intravenosas , Plastificantes , Cloreto de Polivinila/química , Quinina/química , Soluções/química , Temperatura , Fatores de Tempo
3.
Cytobios ; 87(351): 207-16, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9214723

RESUMO

The influence of some linear alkanes on the survival of Escherichia coli natural sea water was investigated. Alkanes with fifteen or more carbon atoms induced a large decrease in viability of E. coli cells in natural sea water. In this case and for concentrations higher than 100 ppm, the loss of viability followed an exponential relationship with the carbon chain length. In the presence of 500 mg l-1 heptane, the survival was 1.6 times higher than that of controls. The progressive disappearance of heptane from the survival medium with a low and temporary accumulation by cells, suggests that this alkane may have been responsible for the increase of cell viability.


Assuntos
Alcanos/farmacologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Água do Mar , Técnicas Bacteriológicas , Heptanos/farmacologia , Cinética , Concentração Osmolar , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA